Mildmay Uganda has launched a five-year research study of rewarding people living with HIV who take their antiretroviral drugs consistently.
This is after several HIV treatment studies by Makerere University, Mildmay and the Ministry of Health indicated that people living with HIV were developing drug resistance to first-line regiment as a result of not taking their prescribed drugs.
According to Dr Yvonne Karamagi, the director of medical services, the study is aimed at accessing the impact of drug adherence and its relationship to treatment failure.
Dubbed: “Behavioural Economics incentives to Support HIV treatment adherence in sub-Saharan Africa (BEST),” the study will recruit about 330 participants in randomized sample.
Ms Harriet Chemusto said the patients will be rewarded annually based on viral load suppression. She said the prizes are a motivation to encourage people to continue taking ARVs.
“If we test you and find that your viral load is suppressed we give a reward,” Ms Chemusto said, adding the patients will be rewarded with items costing not more than Ugx. 5,000.